Drugs / Sevoflurane and Remifentanyl
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01214057 Comparator | May 2010 → Oct 2012 | chronic rhinosinusitis | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sevoflurane and Remifentanyl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01214057 ↗ |
| Route | Intravenous | “After intubation remifentanil infusion will be changed to 0.2 mcg/kg/min” NCT01214057 ↗ |